Jaguar Health, Inc. (113) | Intellectual Property (2)
- License Agreement, dated August 18, 2021, by and between Napo Pharmaceuticals, Inc. and Napo EU S.p.A (Filed With SEC on August 24, 2021)
- License Agreement, dated April 15, 2020, by and between Jaguar Health, Inc. and Atlas Sciences, LLC (Filed With SEC on April 16, 2020)
